Product Categories
| Country: | China |
|---|---|
| Tel: | 0755-26050679 |
| Mobile: | 18318671572 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Trazodone Impurity 23 | C6H6ClN | 95-51-2 | Details |
| Trazodone Impurity 24 | C6H5Cl2N | 554-00-7 | Details |
| Trazodone Impurity 12 | C4H11NO2 | 111-42-2 | Details |
| Clindamycin Impurity 3 | C18H31ClN2O5S | 1440605-51-5 | Details |
| Clindamycin Impurity 20 | C9H13NO | Details |
| Trazodone Impurity 13 | C3H6BrCl | 109-70-6 | Details |
| Pioglitazone HCl | C19H21ClN2O3S | 112529-15-4 | Details |
| Clindamycin Phosphate Impurity 1 | C21H36Cl3N2O6PS | Details |
| Clindamycin B 3-phosphate | Details |
| Clindamycin HCl | C18H34Cl2N2O5S | 21462-39-5 | Details |
| Clindamycin Impurity 1 | C18H33ClN2O5S | 16684-06-3 | Details |
| Pioglitazone Impurity A | C19H20N2O4S | 625853-74-9 | Details |
| Lincomycin 2,4-Phosphate;Clindamycin Phosphate EP Impurity G | Details |
| Pioglitazone EP Impurity B | C19H18N2O3S | 136401-69-9 | Details |
| Pioglitazone EP Impurity D | C21H26N2O4S | 868754-41-0 | Details |
| Pioglitazone Aldehyde HCl | C16H18ClNO2 | 856255-80-6 | Details |
| Indapamide Impurity 1 | Details |
| Indapamide Glucuronide | C16H21NO8 | Details |
| Indapamide Impurity 13 | C7H5Cl2NO3S | 70049-77-3 | Details |
| Pioglitazone Metabolite M1 | C10H9NO3S | 74772-78-4 | Details |
| Indapamide EP Impurity B | C16H14ClN3O3S | 63968-75-2 | Details |
| Indapamide EP Impurity C | C9H12N2 | Details |
| 5-Hydroxy Indapamide | C16H16ClN3O4S | 126750-70-7 | Details |
| Pioglitazone EP Impurity E | C20H25NO3 | 868754-42-1 | Details |
| Pioglitazone Impurity 3 | C34H35N3O4S | 669716-56-7 | Details |
| Pioglitazone Impurity F | C20H16N2O5S2 | Details |
| Indapamide Impurity 11 | C8H7ClO5S | Details |
| Indapamide Impurity 12 | C7H6ClNO4S | 1205-30-7 | Details |
| Indapamide Impurity B | C9H13ClN2 | 31529-47-2 | Details |
| Clindamycin Phosphate EP Impurity F | C18H35N2O9PS | 27480-30-4 | Details |
| Roxithromycin Impurity H | Details |
| Empagliflozin Impurity D | Details |
| Roxithromycin | C41H76N2O15 | 80214-83-1 | Details |
| Empagliflozin Impurity 9 | C13H8BrClO2 | 1360568-68-8 | Details |
| Indapamide | C16H16ClN3O3S | 26807-65-8 | Details |
| Empagliflozin Impurity 2 | C23H27ClO7 | Details |
| Roxithromycin Impurity K | Details |
| Valproic Acid EP Impurity J | C11H21N | 5340-48-7 | Details |
| Roxithromycin Impurity G | C42H78N2O16 | 425365-64-6 | Details |
| Roxithromycin EP Impurity D | C41H76N2O15 | 134931-00-3 | Details |
| Valproic Acid EP Impurity D | C11H22O2 | 52061-75-3 | Details |
| Roxithromycin EP Impurity F | C40H74N2O15 | 118267-18-8 | Details |
| Azithromycin Impurity 20 | C37H68N2O13 | 111321-02-9 | Details |
| Roxithromycin Impurity I | C45H84N2O17 | 425365-66-8 | Details |
| Empagliflozin-13C6 | C23H27ClO7 | 864070-44-0 | Details |
| Empagliflozin Impurity B | Details |
| Roxithromycin EP Impurity J HCl | C40H73ClN2O14 | 134834-12-1 | Details |
| Roxithromycin N-Oxide | C41H76N2O16 | 1460313-73-8 | Details |
| Valproic Acid EP Impurity C | C8H16O2 | 62391-99-5 | Details |
| Empagliflozin Sugar Dimer Impurity | Details |
| Valproic Acid | C8H16O2 | 99-66-1 | Details |
| Empagliflozin Impurity A | Details |
| Roxithromycin Impurity E | Details |
| Empagliflozin Sugar Dimer Impurity 1 | Details |
| Empagliflozin Impurity 7 | C17H16BrClO2 | 915095-89-5 | Details |
| Empagliflozin Impurity 8 | Details |
| Erythromycin;Roxithromycin EP Impurity A | C37H67NO13 | 114-07-8 | Details |
| Empagliflozin Impurity 25 | C4H8O2 | 86087-24-3 | Details |
| Valproic Acid EP Impurity L | C6H12O2 | 97-61-0 | Details |
| Valproic Acid Related Compound A | C8H12O2 | 99-67-2 | Details |
| (1R)-1,5-Dihydroxy Empagliflozin | C23H29ClO8 | 1620758-34-0 | Details |
| Valproic Acid EP Impurity G | C11H23NO | 52061-73-1 | Details |
| Voriconazole EP Impurity B | C16H15F2N5O | 182369-73-9 | Details |
| Tofacitinib Impurity N | C13H19N5 | 1260614-73-0 | Details |
| Tofacitinib Impurity J | C16H21N5O3 | Details |
| Tofacitinib Impurity U | C13H18ClN5 | 1616760-97-4 | Details |
| Indacaterol Impurity 2 | C22H24N2O3 | 1026461-20-0 | Details |
| 5-Hydroxy Valproic Acid Sodium Salt | C8H15NaO3 | 78644-53-8 | Details |
| Voriconazole | C16H14F3N5O | 137234-62-9 | Details |
| Tofacitinib Impurity F | C14H22N2 | 384338-23-2 | Details |
| Tofacitinib Impurity 10 | C13H19N5 | 477600-74-1 | Details |
| Indacaterol Impurity 6 HCl | C13H20ClN | 312753-53-0 | Details |
| Valproic Acid Impurity 10 | C11H20O3 | 109578-13-4 | Details |
| Tofacitinib Impurity R | C13H10ClN3O2S | 479633-63-1 | Details |
| Tofacitinib Impurity 24 | C16H20N6O | 1092578-48-7 | Details |
| Voriconazole Related Compound D | Details |
| Tofacitinib Impurity T | C16H20N6O | Details |
| Valproic Acid EP Impurity B | C7H14O2 | 20225-24-5 | Details |
| Tofacitinib Impurity C Citrate | C16H20N6O | Details |
| Indacaterol Impurity 7 | C31H34N2O3 | 435273-75-9 | Details |
| Tofacitinib Impurity L | C16H22N6O2 | 1675248-19-7 | Details |
| Tofacitinib Impurity I | C14H24Cl2N2 | Details |
| Tofacitinib Impurity W | Details |
| Tofacitinib Impurity X | Details |
| Voriconazole Impurity E | C10H16O4S | Details |
| Tofacitinib Impurity 39 | C27H31N5O2S | 923036-30-0 | Details |
| Valproic Acid Impurity F | C8H16O2 | Details |
| Tofacitinib Impurity 9 | C20H25N5 | 477600-73-0 | Details |
| Tofacitinib Impurity 42 | C16H20N6O | 1092578-46-5 | Details |
| Indacaterol Impurity 1 | C24H30N2O3 | 1403389-05-8 | Details |
| Tofacitinib Impurity V | Details |
| Valproic Acid Impurity 9 | Details |
| Valproic Acid EP Impurity I | C8H15N | 13310-75-3 | Details |
| Indacaterol Impurity 5 | C18H15NO3 | 173140-90-4 | Details |
| Indacaterol Maleate | C24H28N2O3.C4H4O4 | 753498-25-8 | Details |
| Tofacitinib Impurity P | C20H25N5 | 1252883-90-1 | Details |
| (S)-Indacaterol Maleate | C24H28N2O3 | 1235445-80-3 | Details |
| Valproic Acid EP Impurity K | C8H16O2 | 5343-52-2 | Details |
| Voriconazole EP Impurity D;Voriconazole Enantiomer | C16H14F3N5O | 137234-63-0 | Details |
| Voriconazole EP Impurity C | C6H7FN2 | 137234-88-9 | Details |
| Tofacitinib Impurity Q | C6H4ClN3 | 3680-69-1 | Details |
| Tofacitinib Citrate | C16H20N6O.C6H8O7 | 540737-29-9 | Details |
| Valproic Acid related compound B | Details |
| Valproic Acid Related Compound A Sodium Salt | C8H13NaO2 | 76944-37-1 | Details |
| Product Total： Product Page： | ||||
| 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 | ||||